A consensus research agenda for optimising nasal drug delivery
Ben Forbes
(1)
,
Rene Bommer
(2)
,
Jonathan Goole
(3)
,
Marie Hellfritzsch
(4)
,
Wilbur de Kruijf
(5)
,
Pierre Lambert
(6)
,
Grazia Caivano
(7, 4)
,
Alain Regard
(8)
,
Francesca Schiaretti
(7)
,
Marie Trenkel
(4)
,
Laurent Vecellio
(8, 9)
,
Gerallt Williams
(10)
,
Fabio Sonvico
(11)
,
Regina Scherliess
(2)
1
King‘s College London
2 PharmAccel Consulting, Moos
3 ULB - Université libre de Bruxelles
4 Department of Pharmaceutics and Biopharmaceutics, Kiel University
5 Medspray BV
6 Ecole Polytechnique de Bruxelles
7 Chiesi Farmaceutici
8 Nemera Insight Innovation Center, La Verpilière
9 CEPR - Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100
10 Aptar Pharma, Le Vaudreuil
11 Dipartimento di Farmacia,Universita` di Parma and INFM
2 PharmAccel Consulting, Moos
3 ULB - Université libre de Bruxelles
4 Department of Pharmaceutics and Biopharmaceutics, Kiel University
5 Medspray BV
6 Ecole Polytechnique de Bruxelles
7 Chiesi Farmaceutici
8 Nemera Insight Innovation Center, La Verpilière
9 CEPR - Centre d’Etude des Pathologies Respiratoires (CEPR), UMR 1100
10 Aptar Pharma, Le Vaudreuil
11 Dipartimento di Farmacia,Universita` di Parma and INFM